
	Where results make sense

Topic: Multiple Myeloma Research Foundation

Related Topics

Myeloma multiplex

Sinclair Research

research and development

quantitative marketing research

Defense Advanced Research Projects Agency

National Research Council

Digital Research

Joint Nuclear Research Institute

Cray Research

The New School for Social Research

original research

In the News (Sat 28 Nov 09)

Northern Trust

Marvin Harrison

Peter Chernin

Gary Locke

Match Play

Penelope Cruz

Mickey Rourke

AR Rahman

Danny Boyle

Hugh Jackman

	Multiple Myeloma - There's Hope!
		Worse yet, perhaps you were told you have Multiple Myeloma (MM), a disease you likely had never heard of, since it represents only 1% of the total cancer cases in the U.S., but 2% of the cancer deaths.
		Multiple Myeloma is a malignant cancer of the plasma cell, which is a type of white blood cell found in bone marrow and many tissues of the body.
		Importantly, the research and clinical trials and new drugs currently going on and being released related to MM are so extensive and encouraging that many myelomics (a term we coined ourselves) may very well find that this turns out to be a chronic disease (like diabetes) rather than a terminal disease.
	www.cancerlynx.com /myeloma.html (1878 words)

	News - Thalidomide Therapy For Multiple Myeloma Patients May Lengthen Survival
		The researchers note that an estimated 14,600 new patients were diagnosed with myeloma in the United States during 2002 and an estimated 10,800 deaths will be due to myeloma in the same period.
		Multiple myeloma, cancer of the bone marrow, remains an incurable cancer despite advances in high-dose chemotherapy and stem cell transplantation therapy.
		Researchers are looking to thalidomide, as well as other treatments or combinations, to find ways to lengthen the survival of patients with multiple myeloma.
	www.docguide.com /news/content.nsf/news/8525697700573E1885256CAE00582DFD (857 words)

	Current Science News - The Multiple Myeloma Research Foundation (MMRF) Announces 2004 Senior Research and Fellows Award ... (Site not responding. Last check: 2007-10-10)
		MMRF Fellows Awards provide $50,000 to new researchers just entering the field of multiple myeloma and working under the supervision of a research sponsor.
		Founded in 1998, the Multiple Myeloma Research Foundation is the largest non-profit foundation dedicated to the single mission of accelerating the search for a cure for multiple myeloma.
		The MMRF is committed to educating and informing patients, caregivers and physicians of the latest therapeutic approaches in multiple myeloma through symposia, teleconferences, and its cutting-edge website.
	www.biotechfind.com /news/news-Multiple-Myeloma-3821.htm (731 words)

	Boston.com / News / Local / Conn. / Son of "Dear Abby" contributes $1 million for disease research (Site not responding. Last check: 2007-10-10)
		Edward J. Phillips, who was diagnosed with multiple myeloma in 2003, and his wife, Leslye, donated the money to the Multiple Myeloma Research Consortium, based in New Canaan.
		Phillips' donation was given to the research consortium with a request for a matching gift of an additional $1 million by the Multiple Myeloma Research Foundation to support research into a cure for multiple myeloma.
		Multiple myeloma is the second most prevalent blood cancer after non-Hodgkin's lymphoma.
	www.boston.com /news/local/connecticut/articles/2005/01/27/son_of_dear_abby_contributes_1_million_for_disease_research (384 words)

	Multiple myeloma - UPCI \| clinical research \| multiple myeloma program (Site not responding. Last check: 2007-10-10)
		A patient information handout on multiple myeloma, written by the authors of this article, The median age at diagnosis of multiple myeloma is 62 years.
		Multiple myeloma is a form of cancer which affects plasma cells in the bone Bone damage is often the most significant feature of multiple myeloma.
		The Multiple Myeloma program was created in 2001 to focus on the causes of and novel treatments for multiple myeloma.
	globalinfoplus.com /?q=multiple-myeloma (168 words)

	Multiple Myeloma Research Foundation :: REVLIMID News Encouraging for Multiple Myeloma Patients
		The Multiple Myeloma Research Foundation was founded in 1998 by twin sisters Karen Andrews and Kathy Giusti after Kathy was diagnosed with multiple myeloma.
		The MMRF is dedicated to building interdisciplinary collaborations among researchers, pharmaceutical companies and biotech firms, and the National Cancer Institute to improve therapeutic treatments for multiple myeloma patients.
		In addition, the MMRF is committed to educating and informing patients, caregivers and physicians of the latest therapeutic approaches in multiple myeloma through symposia, teleconferences, and its cutting-edge Web site.
	sev.prnewswire.com /health-care-hospitals/20050307/FLM01807032005-1.html (585 words)

	Cancer Help Online...Multiple Myeloma Information
		Multiple Myeloma Research Foundation (USA) MMRF was founded in 1996 by Kathy Giusti who was diagnosed with multiple myleoma at age 37.
		Myeloma Trialists' Collaborative Group (UK) the group are involved in research into multiple myeloma including clinical trials run by the MRC/ICRF/BHF Clinical Trial Service Unit in Oxford.
		National Children's Leukemia Foundation (USA) The NCLF is a non-profit organization providing services, support, and referrals for leukemia patients and their families.The site provides details of their telephone help line, and information on various topics related to childhood leukemia.
	www.cancerhelponline.org /multiple_myeloma_cancer.htm (980 words)

	eMedicine - Multiple Myeloma : Article by Steven M Sorenson, MD (Site not responding. Last check: 2007-10-10)
		Multiple myeloma is responsible for 10% of hematologic malignancies.
		The incidence of multiple myeloma is believed to be the same as in the United States, but it is diagnosed less frequently elsewhere.
		Anatomy: Multiple myeloma is a diffuse disease of the bone marrow.
	www.emedicine.com /radio/topic460.htm (3220 words)

	Knowing Your Treatment Options
		Treatment of myeloma can be a complex process because many variables must be taken into account, such as the patient's overall state of health, other medical issues/diseases, and how well the disease is currently controlled, as well as the type, number, and response to previous therapy.
		Some myeloma groups consider a decrease in M protein between 25% and 50% to be a minimal response whereas others consider this to be stable disease.
		Progressive disease refers to active myeloma that is worsening (ie, increasing M protein and worsening organ or tissue impairment [end organ damage]).
	www.multiplemyeloma.org /treatments (2121 words)

	jensmiles > home (Site not responding. Last check: 2007-10-10)
		jensmiles was my campaign to raise money for multiple myeloma cancer research by trying to walk 2800 miles in one year (8 miles/day).
		Multiple myeloma is a bone/blood cancer that represents approximately 1% of all cancers and 2% of all cancer deaths, including my late father (May 2005).
		My father was diagnosed with multiple myeloma in 1999, but his relapse in 2004 motivated me to get more involved.
	www.jensmiles.com (366 words)

	Charity Navigator Rating - The Multiple Myeloma Research Foundation
		Established in 1998, The Multiple Myeloma Research Foundation (MMRF) is dedicated to accelerating the search for a cure for multiple myeloma.
		Multiple myeloma, a cancer of the plasma cell, is an incurable but treatable disease.
		Currently, the MMRF is funding 20 new therapies now in Phase I, II, and III clinical trials - such as Revlimid - that have shown promise in treating myeloma patients at all stages of disease.
	www.charitynavigator.org /index.cfm/bay/search.summary/orgid/6521.htm (285 words)

	Novel Combination Overcomes Drug-resistant Myeloma Cells (Site not responding. Last check: 2007-10-10)
		Research Shows Existing Diabetes Drugs May Kill Multiple Myeloma (December 15, 2004) -- In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes...
		Highly encouraged by the findings, the researchers hope to move rapidly to clinical trials of the therapy, a combination of the drug Velcade and an experimental compound that was designed by researchers at the Broad Institute of Massachusetts Institute of Technology and Harvard University.
		The research was supported in part by grants from the National Institutes of Health, the Doris Duke Charitable Foundation, and the Multiple Myeloma Research Foundation.
	www.sciencedaily.com /releases/2005/06/050605184058.htm (701 words)

	The Multiple Myeloma Research Foundation (MMRF) Announces 2003 Senior Research and Fellows Award Winners (Site not responding. Last check: 2007-10-10)
		The Multiple Myeloma Research Foundation (MMRF), the world's largest private funder of myeloma-specific research, today announced the awarding of 15 one-year research grants worth nearly $1.2 million to leading myeloma researchers through its Senior Research and Fellows Awards.
		These research projects from leading myeloma researchers were rated among the top 30% of applications by an esteemed panel of reviewers who follow a stringent and objective review process," said Kathy Giusti, President and Co-Founder of the MMRF.
		In 2002, the MMRF funded $4 million for myeloma research, including targeted therapeutics, immune therapy, pathogenesis, and gene array technology, to researchers and institutions worldwide.
	www.forrelease.com /D20030908/nym147.P2.09082003105727.12531.html (201 words)

	Stealth Virus and Multiple Myeloma
		In a well controlled blinded study, all ten blood samples from multiple myeloma patients were scored strongly positive, in contrast to none of the ten control samples.
		Durie confirmed that many of his multiple myeloma patients had a prior, or co-existing, neuropsychiatric illness.
		Multiple myeloma patients interested in such an approach to therapy should relay this information to their clinician.
	www.ccid.org /stealth/clinical/svandmyeloma.htm (612 words)

	Mayo Clinic - Mayo Clinic Inaugurates New Multiple Myeloma Research Program (Site not responding. Last check: 2007-10-10)
		In collaboration with colleagues at the Translational Genomics Research Institute, or TGen, they are focusing their research on myeloma, drug development and genomics.
		The three physician researchers are pioneers for the genetics of myeloma.
		In Arizona, Mayo's clinical and research experts work together to address the complex needs of cancer patients, with a dedication to understanding the biology of cancer; discovering new ways to predict, prevent, diagnose and treat cancer; and transforming the quality of life for cancer patients today and in the future.
	www.mayoclinic.org /news2005-sct/3053.html (712 words)

	The Wellness Community Valley/Ventura
		Funds, promotes, and collaborates on kidney cancer research projects; educates physicians and patients about kidney cancer; and advocates on the federal and state levels on behalf of patient interests.
		The Lymphoma Research Foundation (LRF) is the nation’s largest lymphoma-focused voluntary health organization devoted exclusively to funding lymphoma research and providing patients and healthcare professionals with critical information on the disease.
		The NW Sarcoma Foundation is a non-profit organization, committed to providing education and support to patients and families who are living with this cancer.
	www.twcvv.org /links.asp (3201 words)

	Multiple Myeloma Foundation- Our mission (Site not responding. Last check: 2007-10-10)
		Then I was diagnosed with multiple myeloma, an incurable cancer of the bone marrow.
		The Kathy Giusti Multiple Myeloma Research Foundation was created to fund cancer research for multiple myeloma to improve patient outcomes and to find a cure for the disease.
		The advisors were selected based on their knowledge, experience and dedication in the field of multiple myeloma.
	www.susanprager.com /giusti/mission.html (201 words)

	MMRF (Site not responding. Last check: 2007-10-10)
		Helped by Diana's celebrity, Adella was a powerful voice for multiple myeloma, taking her message of research and progress across the country and raising funds in support of the cause.
		The MMRF served as a guidepost on our mother's journey with multiple myeloma, providing her with a tremendous source of support and inspiration.
		She wholeheartedly believed that progress in multiple myeloma would only be made with an increased commitment to research.
	www.dianakrall.info /id6.html (304 words)

	Research Foundation Awards 3-year Grant To Study Molecular Multiple Myeloma
		The translational research program consists of three core projects: genomic and proteomic profiles of response versus resistance to combination therapies; targeting novel signal transduction pathways in myeloma cells and their bone marrow microenvironment; and defining strategies to overcome in vivo drug resistance.
		MMRF Research Award winners are selected following a peer-review process by the MMRF Scientific Advisory Board using guidelines established by the National Institutes of Health (NIH).
		The MMRF is 1 of 9 private, charitable research organizations in the United States to receive approval since the NCI started the program nearly 10 years ago.
	www.cancercompass.com /cancer-news/1,8096,00.htm (380 words)

	Newswise
		The Multiple Myeloma Research Foundation recognized Celgene for its dedication in the fight against multiple myeloma, and individuals who have helped raise awareness of the disease.
		The Multiple Myeloma Research Foundation is driven by a single purpose: To accelerate the search for a cure for multiple myeloma.
		The mission of the Foundation is to fund cancer research for multiple myeloma, to improve patient outcomes, and to find a cure for the disease.
	www.newswise.com /articles/view/30332 (345 words)

	Cancer-UK: Multiple Myeloma
		Multiple myeloma (also known as myelomatosis or myeloma) is a cancer in which there is abnormal growth in the number of plasma cells in the bone-marrow and blood.
		Multiple myeloma is most common in people aged over 60, and is rare before the age of 40.
		Multiple Myeloma (CancerHelp UK) Information about the cancer, diagnosis, treatment and living with the disease.
	www.cancerindex.org /clink45i.htm (176 words)

	CBBB Wise Giving Alliance
		Multiple Myeloma Research Foundation (MMRF) meets the Standards for Charity Accountability.
		The Foundation also organizes Research Roundtables; international forums for leading experts to discuss emerging therapies in treating multiple myeloma.
		Through it's website, MMRF informs the myeloma community of patient and doctors symposia, electronic and print newsletters, teleconferences, webcasts and educational brochures.
	www.give.org /reports/care_dyn.asp?753 (407 words)

	Myeloma Institute for Research and Therapy: Treating the World’s Multiple Myeloma Patients
		At the Myeloma Institute we treat more patients with Multiple Myeloma than anywhere else in the world, and have one of the most active bone marrow transplantation centers for patients with numerous forms of cancer.
		The Myeloma Institute for Research and Therapy, evolving from the breakthrough advances of the UAMS myeloma program, is committed to accelerating curative therapies for multiple myeloma and related disease entities through innovative clinical and basic science research and outstanding patient care.
		The Myeloma Institute for Research and Therapy has moved to a new location.
	myeloma.uams.edu (362 words)

	CDC Awards Nearly $500,000 To The Multiple Myeloma Research Foundation
		The funds will go directly to support the MMRF Nationwide Patient and Provider Education and Outreach Program to increase awareness of treatment options and clinical trials among physicians, to improve the reach and effectiveness of patient education strategies, and to increase the awareness of multiple myeloma patient resources among patients and providers.
		The MMRF worked closely with Senator Hutchison to introduce this legislation, and continues to work with Senator Hutchison and the Honorable Geraldine Ferraro to advance public policy initiatives that accelerate and intensify efforts to bring new therapies and high quality care to patients everywhere with blood cancers.
		The MMRF was founded in 1998 by twin sisters Karen Andrews and Kathy Giusti to help accelerate the search for a cure for multiple myeloma.
	www.cancercompass.com /cancer-news/1,7728,00.htm (560 words)

	HealthTalk Multiple Myeloma Education Network - Your guide to multiple myeloma symptoms, treatments and resources. (Site not responding. Last check: 2007-10-10)
		Whether you're living with multiple myeloma or caring for someone with this disease, you'll find the latest information and resources right here.
		Multiple myeloma patients are at particular risk for bone complications.
		The HealthTalk Multiple Myeloma Education Network is brought to you in partnership with the International Myeloma Foundation.
	www.healthtalk.com /multiplemyeloma/index.cfm (212 words)

	Multiple Myeloma: Causes, Symptoms and Treatment continued (Site not responding. Last check: 2007-10-10)
		The goal of multiple myeloma treatment is to slow the progression of the disease and to control symptoms.
		Standard multiple myeloma treatment options have too many side effects and too few benefits to be used unless symptoms are present.
		Radiation therapy provides palliative care for multiple myeloma patients, slowing the progression of tumor growth and providing bone pain relief.
	www.multiple-myeloma-treatment.com (403 words)

	Keryx Biopharmaceuticals, Inc. Commences Phase II, Multi-Center Study of KRX-0401 for the Treatment of Refractory ... (Site not responding. Last check: 2007-10-10)
		Perifosine was shown to modulate a number of key cellular functions involved in the replication and death of multiple myeloma cells, and, as in other cell lines, it was shown to be a potent Akt inhibitor.
		Another Keryx-sponsored multiple myeloma clinical study to be launched in the first half of 2006 will be a DFCI -led phase I/II study evaluating the safety and efficacy of KRX-0401 and bortezomib (Velcade(R)) therapy with or without dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with bortezomib (Velcade(R)).
		One of the pathways inhibited by the alkylphosphocholines is Akt, a pathway associated with tumor survival and growth.
	www.forbes.com /prnewswire/feeds/prnewswire/2006/01/03/prnewswire200601030815PR_NEWS_B_MAT_NY_NYTU089.html (1241 words)

Try your search on: Qwika (all wikis)